Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,054 | 1,639 | 90,121 | 106,092 | 201,661 |
| Marketable Securities | 19,928 | N/A | 93,822 | 127,703 | 46,459 |
| Receivables | N/A | N/A | 206 | 157 | 50 |
| TOTAL | $118,809 | $2,606 | $187,635 | $243,052 | $253,348 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 930 | 1,549 |
| Other Non-Current Assets | 2,927 | 3,556 | 3,161 | 33,097 | 31,697 |
| TOTAL | $2,927 | $3,556 | $3,161 | $34,027 | $33,246 |
| Total Assets | $121,736 | $6,162 | $190,796 | $277,079 | $286,594 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 19,541 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,281 | 1,560 | 6,761 | 3,004 | 8,361 |
| Accrued Expenses | 8,117 | 2,195 | 10,086 | 13,985 | 20,152 |
| Other current liabilities | N/A | 1,407 | 739 | 56 | 1,742 |
| TOTAL | $9,714 | $24,703 | $28,367 | $24,338 | $37,853 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 33,208 | 78,075 | 16,648 | 28,222 | 23,475 |
| TOTAL | $33,208 | $78,075 | $16,648 | $28,222 | $23,475 |
| Total Liabilities | $42,922 | $102,778 | $45,015 | $52,560 | $61,328 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,928 | 5,043 | 4,997 | 4,066 | 2,843 |
| Common Shares | 2 | N/A | N/A | 9 | 7 |
| Retained earnings | -159,999 | -116,561 | -656,193 | -465,775 | -297,065 |
| Other shareholders' equity | 6 | 0 | -62 | -468 | -155 |
| TOTAL | $78,814 | $-96,616 | $145,781 | $224,519 | $225,266 |
| Total Liabilities And Equity | $121,736 | $6,162 | $190,796 | $277,079 | $286,594 |